MicrobiologybioRxiv
Development of a novel glycoengineering platform for the rapid production of conjugate vaccines.
S. Abouelhadid, E. Atkins, E. Kay…·J. Cuccui
This paper develops a novel glycoengineering platform, MAGIC, which increases glycoconjugate yield and enables vaccine development in genetically intractable bacteria.
DOI 10.1186/s12934-023-02125-y